Recordkeeping fees per participant
not reported
Not reported on this filing.
Employers › Servier Pharmaceuticals
Servier Pharmaceuticals 401(k)
- Manufacturing
- Boston, MA
- EIN 37-1897970
- 1 plan with Schedule H financials
- Plan year 2024
- Servier Pharmaceuticals LLC
Administrative expenses excluding investment management, per participant · Servier Pharmaceuticals LLC 401(k) Plan · plan year 2024
$167.93
Higher than 79% of the 8,758 plans $50 to 250M that report it.
Source
= $96,561 / 575
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250728112653NAL0004468370001, received 2025-07-28
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250728112653NAL0004468370001, received 2025-07-28
Percentiles compare this plan with the Schedule H plans $50 to 250M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-07-28.
Cost and contributions
Administrative expenses per participant
$230.62
Higher than 77% of the 9,042 plans $50 to 250M that report it.
Source
= $132,606 / 575
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250728112653NAL0004468370001, received 2025-07-28
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250728112653NAL0004468370001, received 2025-07-28
Administrative expenses as a share of assets
0.184%
Higher than 65% of the 9,049 plans $50 to 250M that report it.
Source
= $132,606 / $72,006,570
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250728112653NAL0004468370001, received 2025-07-28
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250728112653NAL0004468370001, received 2025-07-28
Employer contributions per participant
$10,225
Higher than 94% of the 9,105 plans $50 to 250M that report it.
Source
= $5,879,308 / 575
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250728112653NAL0004468370001, received 2025-07-28
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250728112653NAL0004468370001, received 2025-07-28
Employer share of total contributions
35.0%
Higher than 67% of the 9,112 plans $50 to 250M that report it.
Source
= $5,879,308 / $16,788,658
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250728112653NAL0004468370001, received 2025-07-28
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250728112653NAL0004468370001, received 2025-07-28
Plan terms, as stated in Servier Pharmaceuticals LLC's SEC filings
Plan terms are not published in public filings.
Plan features
2E profit-sharing · 2F ERISA 404(c) plan · 2G fully participant-directed · 2J 401(k) feature · 2K 401(m) arrangement · 2S pre-approved plan document · 2T default investment (QDIA) · 3D IRS pre-approved plan · 3H controlled-group sponsor · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20250728112653NAL0004468370001, received 2025-07-28
Full record, Servier Pharmaceuticals LLC 401(k) Plan
| Field | Value | Source |
|---|---|---|
| Plan sponsor | SERVIER PHARMACEUTICALS LLC | Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Plan name | SERVIER PHARMACEUTICALS LLC 401(K) PLAN | Form 5500, line 1a; PLAN_NAME pos 16; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Sponsor EIN / plan number | 37-1897970 / 001 | Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Plan type | single-employer | Form 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Sponsor location | BOSTON, MA | Form 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Industry (business code) | 325410, Manufacturing | Form 5500, line 2d; BUSINESS_CODE pos 46; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Plan year | 2024-01-01 to 2024-12-31 | Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Filing received | 2025-07-28 | Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Final filing | no | Form 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Amended filing | no | Form 5500, Part I line B; AMENDED_IND pos 7; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Participants, beginning of year | 572 | Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Active participants | 495 | Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Participants, end of year | 577 | Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Participants with an account balance | 575 | Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Total assets, beginning of year | $50,499,575 | Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Total assets, end of year | $72,006,570 | Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Net assets, end of year | $72,006,570 | Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Total income | $24,682,665 | Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Net income | $21,506,995 | Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Employer contributions | $5,879,308 | Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Participant contributions | $8,859,461 | Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Other contributions (incl. rollovers) | $2,049,889 | Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Total contributions | $16,788,658 | Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Benefit payments | $3,039,142 | Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Total expenses (incl. benefit payments) | $3,175,670 | Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Total administrative expenses | $132,606 | Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Contract administrator fees | $96,561 | Schedule H, line 2i(2); CONTRACT_ADMIN_FEES_AMT pos 106; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Investment advisory and management fees | $36,045 | Schedule H, line 2i(5); INVST_MGMT_FEES_AMT pos 107; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Administrative expenses excluding investment management | $96,561 | derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Held in mutual funds | $70,639,710 | Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20250728112653NAL0004468370001, received 2025-07-28 |
| Independent auditor | CARON & BLETZER, PLLC | Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20250728112653NAL0004468370001, received 2025-07-28 |
Position = column in the DOL layout for form year 2024. Filing 20250728112653NAL0004468370001, received 2025-07-28.
Service providers paid directly by the plan
| Provider | Relationship | Service codes | Direct compensation | Indirect |
|---|---|---|---|---|
| PRINCIPAL LIFE INSURANCE COMPANYrecordkeeper | CONTRACT ADMINISTRATOR | 13 Contract administrator; 50 Direct payment from the plan; 64 Recordkeeping fees | $96,561 | yes |
| CAPFINANCIAL PARTNERS, | INVESTMENT ADVISORY | 27 Investment advisory (plan); 50 Direct payment from the plan | $36,057 | no |
Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20250728112653NAL0004468370001, received 2025-07-28.
What changed since the 2023 plan year
| Figure | 2023 | 2024 | Change |
|---|---|---|---|
| Total assets | $50,499,575 | $72,006,570 | 42.6% |
| Participants with a balance | 540 | 575 | 6.5% |
| Administrative expenses | $79,922 | $132,606 | 65.9% |
| Recordkeeping fees per participant | not reported | not reported | |
| Employer contributions | $5,257,464 | $5,879,308 | 11.8% |
Prior filing 20241003082223NAL0005580531001, received 2024-10-03; the plan years are contiguous.
Alerts, claims and corrections
Sponsor name as filed: SERVIER PHARMACEUTICALS LLC; SEC registrant: Servier Pharmaceuticals LLC (CIK 1842321, matched by EIN).